{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:15:02Z","timestamp":1772820902467,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Dalian Key Medical Specialty Dengfeng Project, China","award":["2021ZZ242"],"award-info":[{"award-number":["2021ZZ242"]}]},{"name":"the Applied Basic Research Project of Liaoning Province, China","award":["2023JH2\/101300091"],"award-info":[{"award-number":["2023JH2\/101300091"]}]},{"name":"the Medical Science Research Project of Dalian Heart Association, China","award":["DHA2217"],"award-info":[{"award-number":["DHA2217"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>The outcome of maintenance hemodialysis (MHD) remains poor, with cardiovascular death accounting for more than half of all-cause death cases. In this study, cardiovascular mortality and all-cause mortality prediction models were developed to investigate the predictive role of metabolites in MHD patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Clinical and metabolomics data of 135 hemodialysis patients from a single center were collected with a 6-year follow-up. Univariate Cox regression and random forest were respectively applied to preliminarily screen clinical and metabolomics characteristics, followed by multivariate Cox regression for identifying features predicting cardiovascular or all-cause mortality. Multivariate Cox proportional regression risk models were constructed using clinical, metabolomics, and combined features. Subgroup survival differences were compared via risk score stratification.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The combined model showed significant superiority in predicting cardiovascular mortality (3-year AUC\u2009=\u20090.901, 5-year AUC\u2009=\u20090.876), surpassing the clinical-only model (0.868\/0.826) and metabolomics-only model (0.659\/0.641). For all-cause mortality, the combined model demonstrated modest improvement (0.859\/0.834) but still outperformed the metabolomics model (0.534\/0.653). Thirty 5-fold cross-validations confirmed stable performance. High-risk groups had significantly higher cumulative mortality than low-risk groups (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The metabolomics-alone model showed limited predictive performance, but its synergistic integration with clinical indicators further improved the predictive performance of mortality risk models, particularly for cardiovascular mortality.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12882-025-04291-0","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T10:46:19Z","timestamp":1752144379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development of cardiovascular and all-cause mortality risk prediction models for maintenance hemodialysis patients based on metabolomics"],"prefix":"10.1186","volume":"26","author":[{"given":"Lian-Lian","family":"You","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Ting","family":"Kuai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Cheng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"issue":"18","key":"4291_CR1","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.4103\/0366-6999.213961","volume":"130","author":"L Zhou","year":"2017","unstructured":"Zhou L, Zeng X, Fu P. Community Hemodialysis in china: opportunities and Challenges[J]. Chin Med J (Engl). 2017;130(18):2143\u20136. https:\/\/doi.org\/10.4103\/0366-6999.213961.","journal-title":"Chin Med J (Engl)"},{"key":"4291_CR2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2022.02.001","author":"KL Johansen","year":"2022","unstructured":"Johansen KL, Chertow GM, Gilbertson DT, Herzog CA, Ishani A, Israni AK, et al. Am J Kidney Dis. 2022;79(4 Suppl 1):A8\u201312. https:\/\/doi.org\/10.1053\/j.ajkd.2022.02.001. US Renal Data System 2021 Annual Data Report: Epidemiology of Kidney Disease in the United States[J]."},{"issue":"10","key":"4291_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11306-016-1094-6","volume":"12","author":"RD Beger","year":"2016","unstructured":"Beger RD, Dunn W, Schmidt MA, Gross SS, Kirwan JA, Cascante M, et al. Metabolomics enables precision medicine: A white paper, community Perspective[J]. Metabolomics. 2016;12(10):149. https:\/\/doi.org\/10.1007\/s11306-016-1094-6.","journal-title":"Metabolomics"},{"issue":"9","key":"4291_CR4","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1161\/CIRCRESAHA.117.311002","volume":"122","author":"RW McGarrah","year":"2018","unstructured":"McGarrah RW, Crown SB, Zhang G, Shah SH, Newgard CB. Cardiovascular Metabolomics[J]. Circ Res. 2018;122(9):1238\u201358. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311002.","journal-title":"Circ Res"},{"issue":"4","key":"4291_CR5","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.21037\/jtd-21-22","volume":"13","author":"J Muller","year":"2021","unstructured":"Muller J, Bertsch T, Volke J, Schmid A, Klingbeil R, Metodiev Y, et al. Narrative review of metabolomics in cardiovascular disease[J]. J Thorac Dis. 2021;13(4):2532\u201350. https:\/\/doi.org\/10.21037\/jtd-21-22.","journal-title":"J Thorac Dis"},{"issue":"1","key":"4291_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1681\/ASN.2016030374","volume":"28","author":"T Shafi","year":"2017","unstructured":"Shafi T, Powe NR, Meyer TW, Hwang S, Hai X, Melamed ML, et al. Trimethylamine N-Oxide and cardiovascular events in Hemodialysis Patients[J]. J Am Soc Nephrol. 2017;28(1):321\u201331. https:\/\/doi.org\/10.1681\/ASN.2016030374.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"4291_CR7","doi-asserted-by":"publisher","first-page":"747","DOI":"10.2215\/CJN.12691018","volume":"14","author":"J Hu","year":"2019","unstructured":"Hu J, Grams ME, Coresh J, Hwang S, Kovesdy CP, Guallar E, et al. Serum metabolites and cardiac death in patients on Hemodialysis[J]. Clin J Am Soc Nephrol. 2019;14(5):747\u20139. https:\/\/doi.org\/10.2215\/CJN.12691018.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"4291_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000507727","volume":"11","author":"J Zhu","year":"2021","unstructured":"Zhu J, Tang C, Ouyang H, Shen H, You T, Hu J. Prediction of All-Cause mortality using an Echocardiography-Based risk score in Hemodialysis Patients[J]. Cardiorenal Med. 2021;11(1):33\u201343. https:\/\/doi.org\/10.1159\/000507727.","journal-title":"Cardiorenal Med"},{"key":"4291_CR9","doi-asserted-by":"publisher","first-page":"e14316","DOI":"10.7717\/peerj.14316","volume":"10","author":"A Zhang","year":"2022","unstructured":"Zhang A, Qi L, Zhang Y, Ren Z, Zhao C, Wang Q, et al. Development of a prediction model to estimate the 5-year risk of cardiovascular events and all-cause mortality in haemodialysis patients: a retrospective study[J]. PeerJ. 2022;10:e14316. https:\/\/doi.org\/10.7717\/peerj.14316.","journal-title":"PeerJ"},{"issue":"7","key":"4291_CR10","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1093\/ndt\/gfac316","volume":"38","author":"NTD Tran","year":"2023","unstructured":"Tran NTD, Balezeaux M, Granal M, Fouque D, Ducher M, Fauvel J. Prediction of all-cause mortality for chronic kidney disease patients using four models of machine learning[J]. Nephrol Dial Transpl. 2023;38(7):1691\u20139. https:\/\/doi.org\/10.1093\/ndt\/gfac316.","journal-title":"Nephrol Dial Transpl"},{"issue":"7","key":"4291_CR11","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1097\/01.asn.0000019641.41496.1e","volume":"13","author":"JC Longenecker","year":"2002","unstructured":"Longenecker JC, Coresh J, Powe NR, Levey AS, Fink NE, Martin A, et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study[J]. J Am Soc Nephrol. 2002;13(7):1918\u201327. https:\/\/doi.org\/10.1097\/01.asn.0000019641.41496.1e.","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 1","key":"4291_CR12","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1053\/j.ajkd.2006.03.051","volume":"48","author":"Clinical practice guidelines for hemodialysis adequacy","year":"2006","unstructured":"Clinical practice guidelines for hemodialysis adequacy. Update 2006[J]. Am J Kidney Dis. 2006;48(Suppl 1):S2\u201390. https:\/\/doi.org\/10.1053\/j.ajkd.2006.03.051.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"4291_CR13","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1681\/ASN.V451205","volume":"4","author":"JT Daugirdas","year":"1993","unstructured":"Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume kt\/v: an analysis of error[J]. J Am Soc Nephrol. 1993;4(5):1205\u201313. https:\/\/doi.org\/10.1681\/ASN.V451205.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"4291_CR14","doi-asserted-by":"publisher","first-page":"sfae095","DOI":"10.1093\/ckj\/sfae095","volume":"17","author":"M Granal","year":"2024","unstructured":"Granal M, Brokhes-Le Calvez S, Dimitrov Y, Chantrel F, Borni-Duval C, Muller C, et al. External validation of the 2-year mortality prediction tool in Hemodialysis patients developed using a bayesian network[J]. Clin Kidney J. 2024;17(6):sfae095. https:\/\/doi.org\/10.1093\/ckj\/sfae095.","journal-title":"Clin Kidney J"},{"key":"4291_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-025-02236-2","author":"A Okubo","year":"2025","unstructured":"Okubo A, Doi T, Morii K, Nishizawa Y, Yamashita K, Shigemoto K, et al. Predicting 3-year all-cause mortality in patients undergoing Hemodialysis using machine learning[J]. J Nephrol. 2025. https:\/\/doi.org\/10.1007\/s40620-025-02236-2.","journal-title":"J Nephrol"},{"issue":"1","key":"4291_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1053\/j.ajkd.2004.03.023","volume":"44","author":"RL Pisoni","year":"2004","unstructured":"Pisoni RL, Bragg-Gresham JL, Young EW, Akizawa T, Asano Y, Locatelli F, et al. Anemia management and outcomes from 12 countries in the Dialysis outcomes and practice patterns study (DOPPS)[J]. Am J Kidney Dis. 2004;44(1):94\u2013111. https:\/\/doi.org\/10.1053\/j.ajkd.2004.03.023.","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"4291_CR17","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.34067\/KID.0000000000000185","volume":"4","author":"A Armenta-Alvarez","year":"2023","unstructured":"Armenta-Alvarez A, Lopez-Gil S, Osuna I, Grobe N, Tao X, Ferreira Dias G, et al. Removal of middle molecules and dialytic albumin loss: A Cross-over study of medium cutoff and High-Flux membranes with Hemodialysis and Hemodiafiltration[J]. Kidney360. 2023;4(8):1095\u2013102. https:\/\/doi.org\/10.34067\/KID.0000000000000185.","journal-title":"Kidney360"},{"issue":"1","key":"4291_CR18","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12882-023-03191-5","volume":"24","author":"Y Jin","year":"2023","unstructured":"Jin Y, Zhang S, Xiao J, Wang Z, Dong C, You L, et al. Association between serum beta (2)-microglobulin levels and the risk of all-cause and cardiovascular disease mortality in Chinese patients undergoing maintenance hemodialysis[J]. BMC Nephrol. 2023;24(1):170. https:\/\/doi.org\/10.1186\/s12882-023-03191-5.","journal-title":"BMC Nephrol"},{"key":"4291_CR19","doi-asserted-by":"publisher","unstructured":"Czaja-Stolc S, Potrykus M, Ruszkowski J, Debska-Slizien A, Malgorzewicz S, Nutritional Status. Uremic toxins, and Metabo-Inflammatory biomarkers as predictors of Two-Year cardiovascular mortality in Dialysis patients: A prospective Study[J]. Nutrients. 2025;17(6). https:\/\/doi.org\/10.3390\/nu17061043.","DOI":"10.3390\/nu17061043"},{"issue":"1","key":"4291_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12882-021-02579-5","volume":"23","author":"X Zhao","year":"2022","unstructured":"Zhao X, Niu Q, Gan L, Hou FF, Liang X, Ni Z, et al. Thrombocytopenia predicts mortality in Chinese Hemodialysis patients- an analysis of the China DOPPS[J]. BMC Nephrol. 2022;23(1):11. https:\/\/doi.org\/10.1186\/s12882-021-02579-5.","journal-title":"BMC Nephrol"},{"issue":"1","key":"4291_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s11255-017-1740-6","volume":"50","author":"O Ulutas","year":"2018","unstructured":"Ulutas O, Taskapan MC, Dogan A, Baysal T, Taskapan H. Vascular calcification is not related to serum fetuin-A and osteopontin levels in Hemodialysis patients[J]. Int Urol Nephrol. 2018;50(1):137\u201342. https:\/\/doi.org\/10.1007\/s11255-017-1740-6.","journal-title":"Int Urol Nephrol"},{"issue":"6","key":"4291_CR22","doi-asserted-by":"publisher","first-page":"F1160","DOI":"10.1152\/ajprenal.00450.2011","volume":"301","author":"EK Jackson","year":"2011","unstructured":"Jackson EK. The 2\u2019,3\u2019-cAMP-adenosine pathway[J]. Am J Physiol Ren Physiol. 2011;301(6):F1160\u20137. https:\/\/doi.org\/10.1152\/ajprenal.00450.2011.","journal-title":"Am J Physiol Ren Physiol"},{"key":"4291_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.brainres.2014.10.059","volume":"1594","author":"EA Newell","year":"2015","unstructured":"Newell EA, Exo JL, Verrier JD, Jackson TC, Gillespie DG, Janesko-Feldman K, et al. 2\u2019,3\u2019-cAMP, 3\u2019-AMP, 2\u2019-AMP and adenosine inhibit TNF-alpha and CXCL10 production from activated primary murine microglia via A2A receptors[J]. Brain Res. 2015;1594:27\u201335. https:\/\/doi.org\/10.1016\/j.brainres.2014.10.059.","journal-title":"Brain Res"},{"issue":"2","key":"4291_CR24","doi-asserted-by":"publisher","first-page":"H391","DOI":"10.1152\/ajpheart.00336.2011","volume":"301","author":"EK Jackson","year":"2011","unstructured":"Jackson EK, Ren J, Gillespie DG. 2\u2019,3\u2019-cAMP, 3\u2019-AMP, and 2\u2019-AMP inhibit human aortic and coronary vascular smooth muscle cell proliferation via A2B receptors[J]. Am J Physiol Heart Circ Physiol. 2011;301(2):H391\u2013401. https:\/\/doi.org\/10.1152\/ajpheart.00336.2011.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7","key":"4291_CR25","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/01.RES.0000217402.73402.cd","volume":"98","author":"A Wihlborg","year":"2006","unstructured":"Wihlborg A, Balogh J, Wang L, Borna C, Dou Y, Joshi BV, et al. Positive inotropic effects by uridine triphosphate (UTP) and uridine diphosphate (UDP) via P2Y2 and P2Y6 receptors on cardiomyocytes and release of UTP in man during myocardial infarction[J]. Circ Res. 2006;98(7):970\u20136. https:\/\/doi.org\/10.1161\/01.RES.0000217402.73402.cd.","journal-title":"Circ Res"},{"key":"4291_CR26","doi-asserted-by":"publisher","first-page":"108796","DOI":"10.1016\/j.pharmthera.2025.108796","volume":"267","author":"LDA Carvalho","year":"2025","unstructured":"Carvalho LDA, Alves VS, Coutinho-Silva R, Savio LE. B. G protein-coupled purinergic P2Y receptors in infectious diseases[J]. Pharmacol Ther. 2025;267:108796. https:\/\/doi.org\/10.1016\/j.pharmthera.2025.108796.","journal-title":"Pharmacol Ther"},{"issue":"8","key":"4291_CR27","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/s43018-024-00771-8","volume":"5","author":"T Scolaro","year":"2024","unstructured":"Scolaro T, Manco M, Pecqueux M, Amorim R, Trotta R, Van Acker HH, et al. Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance[J]. Nat Cancer. 2024;5(8):1206\u201326. https:\/\/doi.org\/10.1038\/s43018-024-00771-8.","journal-title":"Nat Cancer"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04291-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04291-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04291-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T10:46:20Z","timestamp":1752144380000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04291-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4291"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04291-0","relation":{"references":[{"id-type":"doi","id":"10.1053\/j.ajkd.2022.02.001","asserted-by":"subject"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"31 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed and approved by the institutional medical ethics committee of the Central Hospital of Dalian University of Technology, and the approval number was YN2022-039-06. Prior to data collection, we approved an informed consent waiver application. The present study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"372"}}